Skip to main content
NCBI home page
RNA logoLink to RNA
. 2002 Dec;8(12):1482–1488.

Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.

Beatrice Primerano 1, Flora Tassone 1, Randi J Hagerman 1, Paul Hagerman 1, Francesco Amaldi 1, Claudia Bagni 1
PMCID: PMC1370354  PMID: 12515381

Abstract

The Fragile X mental retardation gene (FMR1) contains a polymorphic trinucleotide CGG repeat in the 5' untranslated region (UTR) of the FMR1 messenger. We have characterized three lymphoblastoid cell lines derived from unrelated male carriers of a premutation that overexpress FMR1 mRNA and show reduced FMRP level compared to normal cells. The analysis of polysomes/mRNPs distribution of mRNA in the cell lines with a premutation shows that the polysomal association of FMR1 mRNA, which is high in normal cells, becomes progressively lower with increasing CGG repeat expansion. In addition, we could detect a very low level of FMR1 mRNA in a lymphoblastoid cell line from a patient with a full mutation. In this case, FMR1 mRNA is not at all associated with polysomes, in agreement with the complete absence of FMRP. The impairment of FMR1 mRNA translation in patients with the Fragile X syndrome with FMR1 premutation is the cause of the lower FMRP levels that leads to the clinical involvement.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardoni Barbara, Mandel Jean-Louis. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr Opin Genet Dev. 2002 Jun;12(3):284–293. doi: 10.1016/s0959-437x(02)00300-3. [DOI] [PubMed] [Google Scholar]
  2. Darnell J. C., Jensen K. B., Jin P., Brown V., Warren S. T., Darnell R. B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 2001 Nov 16;107(4):489–499. doi: 10.1016/s0092-8674(01)00566-9. [DOI] [PubMed] [Google Scholar]
  3. Devys D., Lutz Y., Rouyer N., Bellocq J. P., Mandel J. L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993 Aug;4(4):335–340. doi: 10.1038/ng0893-335. [DOI] [PubMed] [Google Scholar]
  4. Dorn M. B., Mazzocco M. M., Hagerman R. J. Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry. 1994 Feb;33(2):256–264. doi: 10.1097/00004583-199402000-00015. [DOI] [PubMed] [Google Scholar]
  5. Feng Y., Gutekunst C. A., Eberhart D. E., Yi H., Warren S. T., Hersch S. M. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci. 1997 Mar 1;17(5):1539–1547. doi: 10.1523/JNEUROSCI.17-05-01539.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feng Y., Zhang F., Lokey L. K., Chastain J. L., Lakkis L., Eberhart D., Warren S. T. Translational suppression by trinucleotide repeat expansion at FMR1. Science. 1995 May 5;268(5211):731–734. doi: 10.1126/science.7732383. [DOI] [PubMed] [Google Scholar]
  7. Franke P., Leboyer M., Gänsicke M., Weiffenbach O., Biancalana V., Cornillet-Lefebre P., Croquette M. F., Froster U., Schwab S. G., Poustka F. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res. 1998 Aug 17;80(2):113–127. doi: 10.1016/s0165-1781(98)00055-9. [DOI] [PubMed] [Google Scholar]
  8. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. G., Jr, Warren S. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20;67(6):1047–1058. doi: 10.1016/0092-8674(91)90283-5. [DOI] [PubMed] [Google Scholar]
  9. Gedeon A. K., Baker E., Robinson H., Partington M. W., Gross B., Manca A., Korn B., Poustka A., Yu S., Sutherland G. R. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet. 1992 Aug;1(5):341–344. doi: 10.1038/ng0892-341. [DOI] [PubMed] [Google Scholar]
  10. Hagerman R. J., Staley L. W., O'Conner R., Lugenbeel K., Nelson D., McLean S. D., Taylor A. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics. 1996 Jan;97(1):122–126. [PubMed] [Google Scholar]
  11. Kenneson A., Zhang F., Hagedorn C. H., Warren S. T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet. 2001 Jul 1;10(14):1449–1454. doi: 10.1093/hmg/10.14.1449. [DOI] [PubMed] [Google Scholar]
  12. Khandjian E. W., Fortin A., Thibodeau A., Tremblay S., Côté F., Devys D., Mandel J. L., Rousseau F. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum Mol Genet. 1995 May;4(5):783–789. doi: 10.1093/hmg/4.5.783. [DOI] [PubMed] [Google Scholar]
  13. Kozak M. Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome. 1996 Aug;7(8):563–574. doi: 10.1007/s003359900171. [DOI] [PubMed] [Google Scholar]
  14. Loesch D. Z., Hay D. A., Sutherland G. R., Halliday J., Judge C., Webb G. C. Phenotypic variation in male-transmitted fragile X: genetic inferences. Am J Med Genet. 1987 Jun;27(2):401–417. doi: 10.1002/ajmg.1320270219. [DOI] [PubMed] [Google Scholar]
  15. Malter H. E., Iber J. C., Willemsen R., de Graaff E., Tarleton J. C., Leisti J., Warren S. T., Oostra B. A. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet. 1997 Feb;15(2):165–169. doi: 10.1038/ng0297-165. [DOI] [PubMed] [Google Scholar]
  16. Milà M., Castellví-Bel S., Sánchez A., Barceló A., Badenas C., Mallolas J., Estivill X. Rare variants in the promoter of the fragile X syndrome gene (FMR1). Mol Cell Probes. 2000 Apr;14(2):115–119. doi: 10.1006/mcpr.2000.0293. [DOI] [PubMed] [Google Scholar]
  17. Moutou C., Vincent M. C., Biancalana V., Mandel J. L. Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum Mol Genet. 1997 Jul;6(7):971–979. doi: 10.1093/hmg/6.7.971. [DOI] [PubMed] [Google Scholar]
  18. O'Donnell William T., Warren Stephen T. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci. 2002 Mar 20;25:315–338. doi: 10.1146/annurev.neuro.25.112701.142909. [DOI] [PubMed] [Google Scholar]
  19. Oberlé I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boué J., Bertheas M. F., Mandel J. L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 1991 May 24;252(5009):1097–1102. doi: 10.1126/science.252.5009.1097. [DOI] [PubMed] [Google Scholar]
  20. Oostra Ben A. Functions of the fragile X protein. Trends Mol Med. 2002 Mar;8(3):102–103. doi: 10.1016/s1471-4914(02)02271-2. [DOI] [PubMed] [Google Scholar]
  21. Pieretti M., Zhang F. P., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 Aug 23;66(4):817–822. doi: 10.1016/0092-8674(91)90125-i. [DOI] [PubMed] [Google Scholar]
  22. Reiss A. L., Abrams M. T., Greenlaw R., Freund L., Denckla M. B. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med. 1995 Feb;1(2):159–167. doi: 10.1038/nm0295-159. [DOI] [PubMed] [Google Scholar]
  23. Riddle J. E., Cheema A., Sobesky W. E., Gardner S. C., Taylor A. K., Pennington B. F., Hagerman R. J. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard. 1998 May;102(6):590–601. doi: 10.1352/0895-8017(1998)102<0590:piifwt>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  24. Rousseau F., Rouillard P., Morel M. L., Khandjian E. W., Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995 Nov;57(5):1006–1018. [PMC free article] [PubMed] [Google Scholar]
  25. Schaeffer C., Bardoni B., Mandel J. L., Ehresmann B., Ehresmann C., Moine H. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 2001 Sep 3;20(17):4803–4813. doi: 10.1093/emboj/20.17.4803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Signori E., Bagni C., Papa S., Primerano B., Rinaldi M., Amaldi F., Fazio V. M. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency. Oncogene. 2001 Jul 27;20(33):4596–4600. doi: 10.1038/sj.onc.1204620. [DOI] [PubMed] [Google Scholar]
  27. Smeets H. J., Smits A. P., Verheij C. E., Theelen J. P., Willemsen R., van de Burgt I., Hoogeveen A. T., Oosterwijk J. C., Oostra B. A. Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet. 1995 Nov;4(11):2103–2108. doi: 10.1093/hmg/4.11.2103. [DOI] [PubMed] [Google Scholar]
  28. Smits A., Smeets D., Hamel B., Dreesen J., de Haan A., van Oost B. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length. Am J Med Genet. 1994 Jul 15;51(4):497–500. doi: 10.1002/ajmg.1320510440. [DOI] [PubMed] [Google Scholar]
  29. Snow K., Doud L. K., Hagerman R., Pergolizzi R. G., Erster S. H., Thibodeau S. N. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet. 1993 Dec;53(6):1217–1228. [PMC free article] [PubMed] [Google Scholar]
  30. Sutcliffe J. S., Nelson D. L., Zhang F., Pieretti M., Caskey C. T., Saxe D., Warren S. T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992 Sep;1(6):397–400. doi: 10.1093/hmg/1.6.397. [DOI] [PubMed] [Google Scholar]
  31. Tassone F., Hagerman R. J., Chamberlain W. D., Hagerman P. J. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet. 2000 Fall;97(3):195–203. doi: 10.1002/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  32. Tassone F., Hagerman R. J., Loesch D. Z., Lachiewicz A., Taylor A. K., Hagerman P. J. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet. 2000 Sep 18;94(3):232–236. doi: 10.1002/1096-8628(20000918)94:3<232::aid-ajmg9>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  33. Tassone F., Hagerman R. J., Taylor A. K., Gane L. W., Godfrey T. E., Hagerman P. J. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet. 2000 Jan;66(1):6–15. doi: 10.1086/302720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tassone F., Hagerman R. J., Taylor A. K., Hagerman P. J. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet. 2001 Jul;38(7):453–456. doi: 10.1136/jmg.38.7.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tassone F., Hagerman R. J., Taylor A. K., Mills J. B., Harris S. W., Gane L. W., Hagerman P. J. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet. 2000 Mar 13;91(2):144–152. doi: 10.1002/(sici)1096-8628(20000313)91:2<144::aid-ajmg14>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  36. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  37. Weiler I. J., Irwin S. A., Klintsova A. Y., Spencer C. M., Brazelton A. D., Miyashiro K., Comery T. A., Patel B., Eberwine J., Greenough W. T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5395–5400. doi: 10.1073/pnas.94.10.5395. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES